As we emerge from the COVID health emergency, there is widespread agreement that Americans are suffering from inadequate access to mental health care. To shore up community mental health systems, on 23 March 2023, the...more
For the year ending August 2020, provisional data from the Centers for Disease Control and Prevention shows that opioid overdose deaths increased 26.8 percent compared to the previous 12 months, with opioid overdoses...more
The Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), [1] signed into law March 27, 2020, significantly overhauls the federal law that governs the confidentiality of substance use disorder (“SUD”) records at...more
This is the first episode in a series focused on the legal issues surrounding the nationwide opioid crisis. To begin the series, Carla DewBerry discusses the laws and regulations impacting health care providers caring for...more
2/28/2018
/ Attorney General ,
Centers for Disease Control and Prevention (CDC) ,
Controlled Substances ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Health Care Providers ,
Healthcare Fraud ,
Kickbacks ,
Medical Monitoring ,
Opioid ,
OxyContin ,
Pain Management ,
Pharmaceutical Distribution ,
Pharmaceutical Industry ,
Prescription Drugs ,
SAMHSA ,
Substance Abuse